CA Stock MarketDetailed Quotes
MDP Medexus Pharmaceuticals Inc
- 2.260
- +0.050+2.26%
15min DelayMarket Closed Jul 19 16:00 ET
55.28MMarket Cap-161428P/E (TTM)
2.270High2.180Low7.86KVolume2.200Open2.210Pre Close17.62KTurnover3.53052wk High0.04%Turnover Ratio24.46MShares1.44052wk Low-0.014EPS TTM50.12MFloat Cap11.250Historical HighLossP/E (Static)22.18MShs Float0.880Historical Low-0.014EPS LYR4.07%Amplitude--Dividend TTM1.33P/B1Lot Size--Div YieldTTM
Medexus Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -59.79%5.26M | -59.79%5.26M | -11.43%8.21M | 102.15%19.5M | 116.64%15.78M | 30.46%13.07M | 30.46%13.07M | -3.11%9.27M | 18.56%9.65M | -28.57%7.29M |
| -Cash and cash equivalents | -59.79%5.26M | -59.79%5.26M | -11.43%8.21M | 102.15%19.5M | 116.64%15.78M | 30.46%13.07M | 30.46%13.07M | -3.11%9.27M | 18.56%9.65M | -28.57%7.29M |
| -Accounts receivable | 8.64%23.87M | 8.64%23.87M | 9.37%22.23M | 33.16%22.66M | 76.32%25.95M | 64.07%21.97M | 64.07%21.97M | 38.36%20.32M | 20.83%17.02M | -13.63%14.72M |
| -Other receivables | -7.42%3.23M | -7.42%3.23M | 4.17%3.54M | 50.22%5.03M | 125.60%3.49M | 184.83%3.49M | 184.83%3.49M | 251.08%3.4M | 421.96%3.35M | 7.96%1.55M |
| Total current assets | -0.65%72.5M | -0.65%72.5M | 19.70%74.08M | 40.21%79.48M | 64.31%79.5M | 48.58%72.97M | 48.58%72.97M | 32.82%61.89M | 29.07%56.69M | 1.04%48.39M |
| Non current assets | ||||||||||
| -Accumulated depreciation | -28.72%-1.13M | -28.72%-1.13M | 3.59%-1.07M | 1.08%-1M | 1.47%-939K | -0.69%-874K | -0.69%-874K | -30.94%-1.11M | -34.97%-1.02M | -42.03%-953K |
| -Long term equity investment | 24.75%34.15M | 24.75%34.15M | 7,588.02%37.21M | -23.13%23.73M | -32.96%25.44M | -31.24%27.38M | -31.24%27.38M | -98.61%484K | -10.60%30.87M | 7.41%37.95M |
| Non current note receivables | 18.16%8.04M | 18.16%8.04M | --8.67M | --7.92M | --6.93M | --6.81M | --6.81M | ---- | ---- | ---- |
| -Goodwill | -7.73%74.42M | -7.73%74.42M | -6.24%76.79M | -6.34%77.89M | -6.77%79.56M | -7.56%80.66M | -7.56%80.66M | -7.50%81.9M | -7.45%83.16M | -6.78%85.34M |
| Regulatory assets | 7.37%24.03M | 7.37%24.03M | 9.37%22.23M | 33.16%22.66M | 76.32%25.95M | 55.35%22.38M | 55.35%22.38M | 38.36%20.32M | 20.83%17.02M | -13.63%14.72M |
| Total assets | -60.73%161K | -60.73%161K | ---- | ---- | ---- | 31.83%410K | 31.83%410K | ---- | ---- | ---- |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | -63.14%15.74M | -63.14%15.74M | -76.87%15.08M | 62.83%48.36M | 142.77%47.48M | 183.84%42.71M | 183.84%42.71M | 257.51%65.18M | 130.93%29.7M | 19.44%19.56M |
| -Current debt | -63.14%15.74M | -63.14%15.74M | -76.87%15.08M | 62.83%48.36M | 142.77%47.48M | 183.84%42.71M | 183.84%42.71M | 257.51%65.18M | 130.93%29.7M | 19.44%19.56M |
| -accounts payable | -23.71%7.75M | -23.71%7.75M | 56.61%43.35M | 20.46%34.78M | 37.08%34.85M | -15.67%10.16M | -15.67%10.16M | 13.89%27.68M | 7.24%28.88M | 9.01%25.42M |
| -Total tax payable | 6.85%59.18M | 6.85%59.18M | 113.85%64.34M | -16.80%50.42M | -22.52%53.57M | -24.47%55.39M | -24.47%55.39M | -55.98%30.09M | -13.59%60.61M | -22.49%69.13M |
| -Other payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -9.22%1.59M | -31.34%1.44M | -27.25%1.55M |
| Current accrued expenses | 52.56%35.48M | 52.56%35.48M | ---- | ---- | ---- | 35.78%23.26M | 35.78%23.26M | ---- | ---- | ---- |
| Current liabilities | -20.68%66.23M | -20.68%66.23M | -34.05%66.48M | 45.19%94.01M | 82.24%90.58M | 73.56%83.5M | 73.56%83.5M | 116.14%100.81M | 50.32%64.75M | 17.50%49.7M |
| Non current liabilities | ||||||||||
| Non current accrued expenses | -13.46%778K | -13.46%778K | -11.54%843K | -12.44%894K | -22.22%875K | -26.37%899K | -26.37%899K | -23.88%953K | -23.58%1.02M | -20.04%1.13M |
| Derivative product liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | -94.12%256K | -98.03%411K |
| Long term provisions | 24.75%34.15M | 24.75%34.15M | 7,588.02%37.21M | -23.13%23.73M | -32.96%25.44M | -31.24%27.38M | -31.24%27.38M | -98.61%484K | -10.60%30.87M | 7.41%37.95M |
| Total non current liabilities | -9.70%125.41M | -9.70%125.41M | -0.06%130.82M | 15.22%144.44M | 21.30%144.15M | 14.37%138.88M | 14.37%138.88M | 13.83%130.89M | 10.72%125.36M | -9.63%118.84M |
| Shareholders'equity | ||||||||||
| Share capital | 10.69%76.39M | 10.69%76.39M | 10.77%76.39M | 0.59%69.2M | 0.62%69.12M | 0.48%69.01M | 0.48%69.01M | 0.43%68.96M | 1.51%68.8M | 2.90%68.69M |
| -common stock | 10.69%76.39M | 10.69%76.39M | 10.77%76.39M | 0.59%69.2M | 0.62%69.12M | 0.48%69.01M | 0.48%69.01M | 0.43%68.96M | 1.51%68.8M | 2.90%68.69M |
| Additional paid-in capital | 6.17%12.01M | 6.17%12.01M | 8.39%11.88M | 0.72%10.91M | 7.31%11.47M | 8.89%11.31M | 8.89%11.31M | 8.14%10.96M | 1.30%10.84M | 5.98%10.68M |
| Gains losses not affecting retained earnings | 0.24%6.17M | 0.24%6.17M | -1.47%6.3M | -8.94%6.09M | 14.16%5.52M | 55.00%6.16M | 55.00%6.16M | 48.57%6.39M | 54.55%6.69M | 34.47%4.84M |
| Other equity interest | 0.26%2.3M | 0.26%2.3M | 99.49%2.35M | 107.20%2.25M | 109.79%2.31M | 79.30%2.3M | 79.30%2.3M | -22.17%1.18M | -19.35%1.08M | -21.33%1.1M |
| Total equity | -3.47%155.73M | -3.47%155.73M | 9.61%160.38M | 16.77%166.18M | 22.34%166.87M | 15.88%161.33M | 15.88%161.33M | 5.93%146.32M | 3.72%142.31M | -4.60%136.4M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg